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mortality and limitation of life-sustaining therapies in patients with moderate to severe traumatic brain
injury in a Swiss academic tertiary care hospital. Methods: This study was a retrospective single center
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if the ICU length of stay was at least 48 hrs. Factors associated with mortality were investigated. Results:
Mean age was 48 ± 21 years, 72.3% were male, and pre-existing medical conditions were overall rare.
Forty-five patients (26.5%) died within 6 months after TBI (Non-survivors group). Most deaths (n=43,
95.5%) occurred after limitation of life-sustaining therapies. In the multiple binary logistic regression
model age, Protestant religion, hypoxemia during the rescue phase, a higher category in the Marshall
classification and a higher Injury Severity Score were independently associated with death. Conclusion:
At our institution, most deaths of patients with moderate to severe TBI occurred after a deliberate
decision to limit life-sustaining therapies. This decision was associated with age, spiritual belief of the
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Abstract
Aim of the Study: A substantial proportion of deaths of patients in the Intensive Care Unit (ICU) 
follow a decision to limit life-sustaining therapies. Patients with moderate to severe Traumatic 
Brain Injury (TBI) differ from the general ICU population: They are usually younger, previously 
healthy, and often with no advance directives. The objective of this study was to identify factors 
associated with mortality and limitation of life-sustaining therapies in patients with moderate to 
severe traumatic brain injury in a Swiss academic tertiary care hospital.
Methods: This study was a retrospective single center analysis of 170 non-elective admissions to 
the surgical ICU of a Swiss academic tertiary care hospital over a three-year period. Patients were 
eligible for the study if diagnosed with moderate to severe blunt TBI, and if the ICU length of stay 
was at least 48 hrs. Factors associated with mortality were investigated.
Results: Mean age was 48 ± 21 years, 72.3% were male, and pre-existing medical conditions were 
overall rare. Forty-five patients (26.5%) died within 6 months after TBI (Non-survivors group). 
Most deaths (n=43, 95.5%) occurred after limitation of life-sustaining therapies. In the multiple 
binary logistic regression model age, Protestant religion, hypoxemia during the rescue phase, a 
higher category in the Marshall classification and a higher Injury Severity Score were independently 
associated with death.
Conclusion: At our institution, most deaths of patients with moderate to severe TBI occurred after a 
deliberate decision to limit life-sustaining therapies. This decision was associated with age, spiritual 
belief of the patient, hypoxemia in the pre-hospital setting, radiological findings, and severity scores. 
Written advance directives should be encouraged to help surrogate decision makers and physicians 
in the acute and sudden setting of TBI to respect the patient’s willed.
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of Life; GCS: Glasgow Coma Scale; AIS-head Abbreviated Injury Scale of the Head Region; SAPS II: 
Simplified Acute Physiology Score II; LOS: Length of Stay; MV: Days number of days on Mechanical 
Ventilation; RBCs: Red Blood Concentrates; CRRT: Continuous Renal Replacement Therapy; EDH: 
Epidural Mass; tSAH: Traumatic Subarachnoid Hemorrhage; GOS: Glasgow Outcome Scale; SD: 
Standard Deviation; IQR: Interquartile Range; OR: Odd-Ratio; CI: Confidence Interval
Introduction
Despite large regional and cultural variations, a large proportion of deaths in the Intensive 
Care Unit (ICU) occur after a deliberate process of limiting life-sustaining therapies [1-3]. Several 
determinants to the decision have been identified, including patient characteristics, disease process, 
therapeutic interventions, level of the acute care center- due to variation in physicians’ perceptions 
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of long-term prognosis and physicians’ practice patterns for 
recommending limitation of life-sustaining therapies-, and Surrogate 
Decision-Makers (SDM) [2-5].
Traumatic Brain Injury (TBI) is the consequence of an acute 
and sudden event and represents the leading cause of death and 
disability in young adults [6]. Patients with moderate to severe TBI 
differ from the general ICU population. They are generally younger, 
previously healthy, and in most cases have not discussed or written 
down Advance Directives (AD) addressing their actual situation 
[7]. Furthermore, patients with TBI often in the acute phase do 
not have the possibility to communicate their preferences allowing 
to base therapeutic options on his or her presumed will. Moreover, 
SDM might be overwhelmed by the situation and might not serve 
as surrogate since they never discussed the situation with the patient 
before the accident. In addition, the existing prognostic models are 
helpful, but not designed to aid decision making on individual patient 
level [8-10].
In the past decades, an increasing trend of limitation of life-
sustaining therapies has been observed in TBI patients in a Scottish 
unit [11]. Little is known about the factors contributing to the decision 
to suspend life-sustaining therapies in patients with TBI. A survey of 
intensivists, neurosurgeons, and neurologists participating in the care 
of TBI patients revealed wide variations concerning the use and the 
assessment of the usefulness of different prognostic predictors and 
tests (physical exam, Computed Tomography scan (CT), magnetic 
resonance imaging, and electrophysiology tests). Equally, there are 
significant uncertainties regarding the determination of prognosis 
and the decision process to limit life-sustaining therapies among 
responders [12]. Cote et al. [2] and Thompson et al. [13] identified 
some head CT-findings and an effect of intensity of care on mortality 
in patients with TBI. However, estimation of patient’s will, religion 
and spiritual believes which legally have to build the base for the 
decision and also statistically have an influence were not included in 
their analysis [14-16]. Exclusion of actual or presumed will from the 
decision process is particularly problematic, since in some countries-
such as Switzerland- respecting the actual or presumed will of the 
patients is mandatory.
This study aims to describe factors associated with mortality and 
having influenced the decision to limit life-sustaining therapies in 
patients with moderate and severe TBI admitted to our unit over a 
period of three years, and to relate the findings to existing data.
Material and Methods
This retrospective cohort study was performed at the surgical ICU 
of the University Hospital of Zurich, a level I Swiss Trauma Center, 
in compliance with the Declaration of Helsinki and the national legal 
and regulatory requirements, and was approved by the local Ethics 
Committee (KEK-ZH-Nr. 2016-00332, April 2016). Data acquisition 
followed the current Swiss regulations with no need for an explicit 
written informed consent.
Inclusion criteria were admission to the surgical ICU between 1 
January 2012 and 30 June 2015 with diagnosis of blunt TBI (ICD Code 
S00-S09) by identification using the hospital’s electronic database 
(KISIM™, Cistec® Zurich, Switzerland), and aged 16 or older. The 
classification as moderate or severe was based on the initial Glasgow 
Coma Scale (GCS <13) before sedation and intubation. Data were 
collected and medical charts were reviewed from the investigators.
Exclusion criteria were discharge from the ICU and death within 
48 hr to avoid the inclusion of patients with initially over-estimated 
severity and no need of an intensified treatment, e.g. due to alcohol- or 
drug-influence at the time of trauma [17], and patients who deceased 
in the emergency room or before a meeting with the SDM was 
organized. At our institution a meeting with the SDM is held within 
48 hrs from injury to identify goals of care based on documented or 
assumed patient’s will. Treatment of TBI patients was based on an 
internal protocol, referring to international guidelines [18].
Baseline demographic and pre-hospital data, severity and 
prognostic scores, and intensity of care at the ICU were collected. 
Baseline demographic data included age, sex, religion, previous 
medical conditions (stroke, past TBI, epilepsy, diabetes mellitus, 
cardiovascular disease, use of anticoagulants and antiplatelet agents, 
psychiatric disorder and history of alcohol or drug abuse), presence 
of written ADs, and/or information on whether the patient discussed 
EOL issues with his or her next of kin before trauma. Pre-hospital 
data covered mechanism of injury (traffic accident, fall or other 
causes), hypotension (defined as systolic blood pressure <90 mmHg), 
hypoxemia (defined as SpO2 <90%), and pupillary reactivity during 
the rescue phase. Pupillary reactivity was considered pathological if 
one or both pupils presented no response to light. Severity scores 
included GCS before sedation and intubation, Injury Severity Score 
(ISS) [19], the Abbreviated Injury Scale of the head region (AIS-
head) [20], and the Simplified Acute Physiology Score II (SAPS II) 
[21]. The IMPACT score, a prognostic model to predict mortality 
and unfavorable outcomes 6-months after TBI was calculated 
[22]. The IMPACT model is based on age, clinical findings (GCS 
motor component, pupillary reactivity), computed tomographic 
characteristics, secondary insults (hypoxemia, hypotension), and on 
laboratory values on admission (glucose, hemoglobin).
Intensity of care during the ICU stay was evaluated with the 
ICU-Length of Stay (LOS), the number of days on Mechanical 
Ventilation (MV-days), use of vasoactive drugs, amount of Red Blood 
Concentrates (RBCs), and use of Continuous Renal Replacement 
Therapy (CRRT). ICU mortality (ICU-mortality) was noted.
The Marshall classification of head injury was used based 
Figure 1: Study population.
Patients included in the study. TBI: Traumatic Brain Injury; ICU-LOS Length 
of Stay at the Intensive Care Unit; EOL: End of Life
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on the first Computerized Tomography (CT) after trauma [23]. 
Particularly, the presence of Epidural Hematoma (EDH) and 
traumatic Subarachnoid Hemorrhage (tSAH) were noted. Long-term 
functional outcome was assessed with the Glasgow Outcome Scale 
(GOS) 6 months after trauma with a structured questionnaire and an 
interview of the patients [24].
For the analysis, patients were split in two groups based on GOS: 
Survivors includes patients still alive 6 months after injury (GOS ≥ 
2), and non survivors includes patients who died 6 months following 
TBI (GOS 1). For non survivors, time of death (expressed in number 
of days after TBI), and place of death (ICU or normal ward, long-term 
care facilities, home) were collected.
The decision to limit life-sustaining therapies was classified as 
withholding or withdrawing treatment. Withholding treatment 
defines the decision not to start or increase a life-sustaining 
intervention (e.g. an order not to resuscitate). Withdrawing treatment 
refers to the active decision to stop provision of a life-sustaining 
intervention (e.g. vasopressors). Furthermore, timing of decision to 
limit the life-sustaining therapies (expressed in number of days after 
trauma), time of death after the decision (expressed in number of 
days after the decision was taken), and people involved in the decision 
(SDM, legal guardian) were collected.
For descriptive statistics, categorical variables were expressed as 
absolute numbers with percentages, normally distributed quantitative 
variables as mean ± Standard Deviation (SD) and non-normally 
distributed variables as median with Interquartile Range (IQR). The 
Kolmogorov-Smirnov test was used to verify normal distribution of 
continuous variables. Comparisons between the Survivors and the 
non survivors were performed with student’s t test, Mann-Whitney 
test, Chi-square or Fisher’s exact test, as appropriate. By statistically 
significant p-value, post-hoc tests were performed, taking into 
account the multi-comparison procedure. In order to identify risk 
factors associated with death, potential predictor variables were first 
selected by univariate analysis. Predictors with p<0.1 were entered 
into a multiple binary logistic regression model and mortality was the 
outcome variable. Goodness of fit of the regression was performed 
with the standard regression model [25]. The Odds-Ratios (ORs) were 
calculated and expressed with the corresponding 95% Confidence 
Intervals (95% CI). Statistical significance was set at p value <0.05 
for all analyses. All analyses were performed using Stata version 12.1 
(StatCorp. LP, College Station, TX, USA).
Results
During the study period, 994 patients with TBI were admitted 
to the surgical ICU. Of those, 170 fulfilled the inclusion criteria of 
the study (Figure 1). Mean age was 48 ± 21 years and 72.3% of the 
patients were male. Baseline demographic data, pre-hospital data, 
severity and prognostic scores, and intensity of care at the ICU of the 
study population overall are presented in Figure 2-5.
In the Survivors group (n=125, 72% male) mean age was 44 ± 
19 years, while in the non-survivors group (n=45) patients were 
significantly older (mean age 61 ± 22 years, p<0.0001; 73.3% male). 
Baseline data and pre-existing medical conditions are listed in Figure 
2. The two groups differed in frequency of cardio-vascular disease and 
use of anticoagulants/antiplatelet agents, which were significantly 
higher (p=0.033 and p<0.0001, respectively) in the non-survivors 
group. Pre-hospital data are presented in Figure 2. In particular, 
hypoxemia during the rescue phase occurred significantly more often 
in the non-survivors group (p=0.014).
Based on the Marshall classification, the survivor group includes 
significantly less patients with categories IV and VI than non-
survivors. Furthermore, the rate of tSAH on the first CT-scan was 
significantly higher in the non-survivors group, as shown in Figure 3.
Concerning severity, based on ISS, SAPS II and IMPACT, patients 
Figure 2: Baseline demographic data and pre-hospital data of the study population.
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in the non-survivors group had higher scores and consequently 
higher likelihood of unfavorable outcome compared to patients in 
the survivors group, as shown in Figure 4.
Intensity of care during the ICU stay did not differ between 
groups, as shown in Figure 5.
The majority of patients of the non-survivors group (n=43; 95.5%) 
died after a decision to limit life-sustaining therapies. In the majority 
of the cases life-sustaining therapies were withdrawn (overall, n=38, 
22.3%, Survivors vs. non-survivors p<0.0001). Patients died 14 ± 16 
days after trauma and 2 ± 2.7 days after EOL decision. Overall, only 
few patients in the study population had written ADs (n=10, 5.9%) or 
discussed EOL issues at least once with the SDM before TBI (n=22, 
13%). In the Non-survivors group presence of written ADs and 
EOL issues discussion with the SDM prior to TBI were significantly 
more frequent than in the Survivors group (p=0.023 and p<0.0001, 
respectively), as shown in Figure 2. A next of kin was the SDM in the 
majority of the cases (97.6%), in both groups.
In the univariate logistic regression analysis mortality was 
associated with age (OR 1.04, CI 1.02-1.06, p<0.001), Protestant 
religion (OR 4.18, CI 1.79-9.74, p=0.001), previous cardio-vascular 
disease (OR 2.14, CI 1.05-4.34, p=0.035), use of anticoagulants/
antiplatelet agents (OR 5.19, CI 2.21-12.18, p<0.001), hypoxemia 
during the rescue phase (OR 2.49, CI 1.19-5.20, p=0.015), a higher 
category in the Marshall classification (OR 1.5, CI 1.20-1.88, 
p<0.0001), presence of tSAH on the first head-CT scan (OR 2.85, 
CI 1.17-6.91, p=0.021), code 4 of the AIS-Head (5.34, CI 1.43-19.91, 
p=0.013), ISS (OR 1.03, CI 1.00-1.06, p=0.033), and SAPS II (OR 1.04, 
CI 1.02-1.07, p<0.001).
Figure 3: Marshall Classification of the study population.
Figure 4: Severity and prognostic scores of the study population.
Figure 5: Intensity of care for the study population.
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In the multiple logistic regression model, age, Protestant religion, 
hypoxemia during the rescue phase, a higher category in the Marshall 
classification and a higher ISS were independently associated with 
mortality, as shown in Figure 6.
Discussion
The present study was conducted to evaluate factors associated 
with mortality in patients with moderate to severe TBI. Few studies 
have focused on this patient group [2,7,8,13,26], which are usually 
younger and have less comorbidities than the general critically ill 
population.
We conducted a multiple binary logistic regression analysis to 
identify factors associated with mortality. Because mortality occurred 
in the study population mostly due to non-sudden deaths following 
EOL decisions, we can speculate that its predictors were also crucial 
aspects for the decision to limit life-sustaining therapies.
As expected, also in this study TBI primarily affected young 
and previous healthy individuals. Furthermore, probably due to the 
sudden nature of TBI in younger patients, the existence of written 
ADs was extremely low (ca. 6% of the study population) and similar 
to a previous report [7]. This is notable, since in Switzerland- after 
the introduction of the new law for the protection of adults (2013) 
[27] - all inhabitants are encouraged to provide written ADs and to 
designate a SDM. Older patients with chronic or terminal illnesses 
and their physicians are more likely to actively fulfill this task, and 
also physicians in regions where Advance care planning is not part 
of the health care system actively bring this up with these patients 
[28,29]. ADs contain personal therapeutic goals and, particular 
for Switzerland, consent or dissent to specific medical measures. 
Furthermore, ADs commonly name one or more SDMs who, in 
case of incapability of decision-making by the patient- as in case of 
severe TBI, are appointed to decide on behalf of the patient based on 
documented or presumed patient’s will.
In the study population and comparable to previous findings 
nearly all deaths (95.5%) occurred after an EOL decision [7,26] and, 
similar to data referring to the critically ill population in the general 
ICU [1,3], withdrawal of life-sustaining therapies was the most 
frequent kind of EOL decision. At our unit, these decisions occur only 
after reviewing any ADs that may exist, after extensive discussions 
with the SDM, and with the approval of both the family and the care 
team, which usually includes intensivists, ICU-nurses, neurosurgeons, 
trauma surgeons, and clinical ethicists. In contrast to individual 
decision and prognostic scores, this multifactorial approach from 
several perspectives could help to improve the decision to limit life-
sustaining therapies.
Similar to previous studies referring to patients with TBI [26] 
and to the general ICU population [3,30], increasing age was 
associated with limitation of life-sustaining therapies. Interestingly 
and different to the findings from Thompson et al. [13], even 
though patients in the Non-survivors group were significantly older 
than patients in the survivors one, both groups received during 
their ICU stay similar duration of treatment (ICU-LOS, MV-
days), frequency of rescue therapies for intracranial hypertension 
(barbiturate coma, decompressive craniectomy), and general ICU-
therapies (vasopressors, CRRT and RBCs), so that we can postulate 
that an advanced age was associated with death and indirectly with 
limitation of life-sustaining therapies but not with reduced intensity 
of treatment per se.
How physician‘s and patient‘s religions influence the use of EOL 
therapies has been rarely investigated [26]. To our knowledge, this 
is the first study to evaluate the possible role of patient’s religion 
in a population with TBI. The Ethicus study revealed that in the 
European general ICUs physicians who are Protestant, Catholic, or 
with no religion more frequently use withdrawal of life-sustaining 
treatments than physicians who are Greek Orthodox, Jewish, or 
Moslem. Our results reveal that mortality and indirectly limitation 
of life-sustaining therapies were also associated with the Protestant 
religion of the patient. Traditionally, Switzerland has been a country 
with strong secularism with no state religion, however with an 
important Protestant and Catholic tradition, which is about evenly 
balanced within the Swiss population. Even if the patients in the 
majority of the cases did not participate in the EOL discussion due 
to the neurological impairment, it seems that their spiritual believes 
were crucial factors influencing the EOL decision-making.
Similar to the results of Diringer et al. [5] in the setting of a 
neurology/neurosurgery ICU, the severity of the acute condition, 
expressed by a higher category in the Marshall classification of head 
injury and a higher ISS, influences mortality and the decision to 
limit life-sustaining therapies. Thus, this result shows that decisions 
to limit life-sustaining therapies are strongly influenced not only 
by the probability of mortality, but also by the predicted morbidity 
attributable to the neurological insult. Prognostication which is 
needed to guide physicians and SDM to approve or refuse medical 
treatments based on documented or assumed patient’s preferences 
has, however, several limitations. Most prognostic models, in fact, 
are limited to their use for the first hours or days after TBI only, do 
not consider the evolution of the cerebral damage several days after 
trauma, and were not developed with the specific aim of influencing 
EOL decisions [8]. In addition, physicians` perceptions of neurologic 
prognosis have an important impact on the decision-making process, 
even though it is known that this perception is highly variable among 
physicians and based on personal experience, competence, and 
spiritual belief [12].
Figure 6: Univariable and in multivariable logistic regression analysis.
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Our study has some limitations. First, it investigated patients 
admitted to a single ICU in a single institution; consequently it is 
possible that other institutions or different management styles would 
yield different results. Furthermore, the outcome variable of the 
study was mortality. Because almost the totality of deaths followed 
a redirection of care to limitation of life-sustaining therapies, we 
postulate that factors associated with death also influenced the EOL-
decisions. Additionally, due to the retrospective design of the study, 
the observed data were limited to the information detailed in the 
patients’ chart and no causal inferences are possible. Finally, because 
of limitations of our database, we did not investigate the influence 
of other relevant factors such as, for example, physician’s attitudes 
about futile care that has been shown to influence decisions to limit 
life-sustaining therapies [3].
Processes leading to a limitation of life-sustaining therapies are 
complex, variable, and multifactorial, and represent an important 
topic and issue in particular in neurocritical care. Even if our analysis 
refers to a regional experience, our findings might contribute to better 
understand the delicate process of decision-making at the end of life.
In conclusion, the majority of deaths of patients with moderate to 
severe TBI at our institution follow a decision to limit life-sustaining 
therapies. Written ADs help SDMs and physicians in the acute and 
sudden setting of TBI to respect the patient’s willed. Their writing 
should be encouraged in an intensive regionally implemented advance 
care planning concept even among young people to evoke and support 
patient’s reflections on their preferences for treatment goals in severe 
TBI also regarding a permanent vegetative or minimally conscious 
state as a potential outcome [34]. Age, spiritual belief of patients, 
hypoxemia in the pre-hospital setting, outcome prognostication 
based on the Marshall classification and the ISS influenced death and 
indirectly the decision to limit life-sustaining therapies. Due to the 
conceptual limitation of current prognostication models, improved 
and multifactorial approaches to predict neurologic outcome are 
needed.
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